SQURPHARMA: Annual Earnings Update FY23

Square Pharmaceuticals Limited (SQUARE BD) posts 4.5% YoY profit growth in FY23

SQAURE BD’s profit increased by 4.5% YoY in FY23. The company also reported 3.1% YoY net profit growth in 4QFY23.

·         While other top drug makers saw their profits drop in FY23 due to BDT depreciation, high inflation, higher raw material costs, and foreign exchange losses, SQUARE BD managed to keep growing its profits.

·         The company’s board approved a plan to spend BDT 4bn on improving and expanding operations, including purchasing machinery and land for future growth.

·         The company declared 105% cash dividend for FY23.

Particulars4QFY224QFY23YoY growthFY22FY23YoY growth
EPS (BDT)4.454.593.1%20.4821.414.5%
NAVPS (BDT)   118.68129.959.5%